Search - tctmd.com

Displaying 1 - 20 of 128

Sort: Relevancy | Date

News Daily News

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Michael O'Riordan

January 26, 2026

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Todd Neale

November 08, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Daily News

Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed

Michael O'Riordan

August 03, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

Advertisement

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Surgeons Support Proposed Changes to Left Main CAD Guidelines

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content